We are live on ! Find out more
CYTK icon

Cytokinetics

108 hedge funds and large institutions have $366M invested in Cytokinetics in 2017 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

591% more call options, than puts

Call options by funds: $4.32M | Put options by funds: $626K

75% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 16

21% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 29

13% more capital invested

Capital invested by funds: $323M → $366M (+$42.7M)

7% more funds holding

Funds holding: 101108 (+7)

2.73% more ownership

Funds ownership: 65.48%68.21% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
108
Holders Change
+7
Holders Change %
+6.93%
% of All Funds
2.69%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
28
Increased
35
Reduced
29
Closed
16
Calls
$4.32M
Puts
$626K
Net Calls
+$3.7M
Net Calls Change
+$3.76M
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
76
State Board of Administration of Florida Retirement System
Florida
$192K
Squarepoint
77
Squarepoint
New York
$188K +$51.3K +4,390 +43%
Susquehanna International Group
78
Susquehanna International Group
Pennsylvania
$185K -$565K -48,302 -77%
UBS Group
79
UBS Group
Switzerland
$183K +$24.1K +2,060 +17%
VOYA Investment Management
80
VOYA Investment Management
Georgia
$181K
Royal Bank of Canada
81
Royal Bank of Canada
Ontario, Canada
$180K +$139K +11,878 +556%
PPA
82
Parametric Portfolio Associates
Washington
$171K +$2.21K +189 +1%
Bank of America
83
Bank of America
North Carolina
$162K +$39.5K +3,383 +37%
LP
84
LMR Partners
United Kingdom
$156K +$142K +12,118 New
Bank of Montreal
85
Bank of Montreal
Ontario, Canada
$154K -$1.91K -163 -1%
LCM
86
Leisure Capital Management
California
$142K -$3.52K -301 -3%
Dimensional Fund Advisors
87
Dimensional Fund Advisors
Texas
$134K +$122K +10,400 New
Legal & General Group
88
Legal & General Group
United Kingdom
$119K -$1.2K -103 -1%
SG Americas Securities
89
SG Americas Securities
New York
$106K -$85.3K -7,297 -47%
Barclays
90
Barclays
United Kingdom
$95K -$92.6K -7,922 -52%
FDCDDQ
91
Federation des caisses Desjardins du Quebec
Quebec, Canada
$66K +$60K +5,133 New
LTFS
92
Ladenburg Thalmann Financial Services
Florida
$40K +$12.9K +1,100 +55%
AIP
93
Ameritas Investment Partners
Nebraska
$36K +$33.1K +2,836 New
PA
94
Parallel Advisors
California
$27K -$11.7K -1,000 -37%
AIM
95
Acrospire Investment Management
Illinois
$19K -$11.7K -1,000 -40%
GWM
96
Geneos Wealth Management
Colorado
$12K
TDC
97
Thompson Davis & Co
Virginia
$10K +$8.77K +750 New
AG
98
Advisor Group
Arizona
$9K
LWM
99
Lenox Wealth Management
Ohio
$8K
Federated Hermes
100
Federated Hermes
Pennsylvania
$6K

CYTK Hedge Fund Activity: Q1 2017 in Review

108 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q1 2017, worth a combined $366M — up 13% from $323M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new CYTK positions and 16 closed out — a net gain of 12 holders — while 35 added to existing stakes and 29 trimmed.

The largest buyer was BlackRock, adding an estimated $35.5M. The largest seller was BVF Inc, cutting an estimated $6.91M.

  • 108 institutional investors held Cytokinetics (CYTK) as of Q1 2017, up from 101 in Q4 2016.
  • Funds reported $366M of Cytokinetics stock for Q1 2017, up 13% quarter-over-quarter.
  • 28 funds opened new Cytokinetics positions in Q1 2017 and 16 closed out, a net change of +12 holders.
  • The largest Cytokinetics buyer in Q1 2017 was BlackRock, an estimated $35.5M added.
  • The largest Cytokinetics seller in Q1 2017 was BVF Inc, an estimated $6.91M sold.

Based on aggregated 13F filings for Q1 2017.